Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Selected for Global Lighting Brand LEDVANCE’s Sun@Home Family Products for Human Centric Lighting
Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED technology, announced that its SunLike Series natural spectrum LEDs, which implement light that closely matches the spectrum of sunlight, has been adopted by Global lighting brand LEDVANCE for its new family of products Sun@Home.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211013005089/en/
LEDVANCE Sun@Home family designed with SunLike Series natural spectrum LEDs (Graphic: Business Wire)
Sun@Home is a premium product line that delivers residential lighting with the best quality of the light. After more than a year of Covid workers and employees are spending much more time in home office work and light is key for having the right environment to be comfortable, concentrated and relax at the same time. SunLike technology is proven to deliver the best light quality for humans. Sun@Home products are all equipped with a smart controller that allows the light to adapt the spectrum to the required needs of the user. SunLike is the only LED that is capable to simulate the Sunlight spectrum from the early morning to sunset when the Sun goes down. The state-of-the-art automated wireless system from LEDVANCE makes it easy to control and adjust the different working modes and light spectrums to stimulate the user in the right way depending on the tasks to do. With SunLike Series natural spectrum LEDs, the fixtures and bulbs are designed to bring out the natural color tones of objects achieving a lower blue light peak, similar to the sunlight spectral curve, which enables the reduction of scattered reflection and glare. It also provides healthy and comfortable light, improving the environment for living, reducing eye fatigue, and displaying colors and textures more accurately with CRI 97 and TM30 = 100 for any CCT from 2200K to 5000K range.
There has been a significant increase in research activity on the relationship between light and human bio-functions, including a recent scientific study focused on the effects of light spectrum on sleep quality, visual comfort, overall well-being, and daytime alertness; encompassing the interaction of both visual and non-visual light on humans. Based on the results of a comprehensive sleep study conducted by Professor Christian Cajochen and his colleagues at the University of Basel in Switzerland, SunLike Series natural spectrum LEDs have been identified as a key light source for promoting human well-being. The study, published in the Journal of Lighting & Research Technology on March 24, 2019, found “evidence that a daylight [natural spectrum] LED solution has beneficial effects on visual comfort, daytime alertness, mood, and sleep intensity in healthy volunteers.”
“Seoul Semiconductor’s SunLike Series natural spectrum LEDs have three beneficial effects in contrast to conventional LEDs: Better Sleep – improvement in sleep quality, Better Eye Health – protection from myopia in children; and Better Study – support for students’ learning and concentration,” said Oliver Schäfer, Executive Vice President Europe of Seoul Semiconductor. “Together with LEDVANCE we are starting a new revolution in the consumer market as we are bringing the best available professional light until now reserved to Museums and Premium products to the mass market. Thanks to LEDVANCE and his vision for the future for human centric lighting for indoor design the spectrum of natural sunlight will provide beneficial effects for all humans improving their health and well-being” added him.
SunLike Series LEDs are an advanced technology that has achieved the highest level of eye safety certification from the International Commission on Illumination as a safe light source with no photo-biological risks and is the only LED certified as Diamond Color Rendering Class by the UL laboratories.
Introduced in June 2017, the SunLike Series natural spectrum LEDs are an advanced light source that combines the latest optical and compound semiconductor technology of Seoul Semiconductor with Toshiba Materials’ TRI-R® technology. TRI-R, supported by Toshiba Materials, finds in the definition “The light closest to the sun for human well-being” its original concept. The sun light spectrum is developed by the same company and can be reproduced by a white LED light source technology.
About Seoul Semiconductor
Seoul Semiconductor develops and commercializes LEDs for automotive, general illumination, specialty lighting, and backlighting markets. As the second-largest LED manufacturer globally excluding the captive market, Seoul Semiconductor holds more than 14,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as SunLike – delivering the world’s best light quality in a next-generation LED enabling human-centric lighting optimized for circadian rhythms; WICOP – a simpler structured package-free LED which provides market leading color uniformity and cost savings at the fixture level, providing high lumen density and design flexibility; NanoDriver Series – the world’s smallest 24W DC LED drivers; Acrich, the world's first high-voltage AC-driven LED technology developed in 2005, including all AC LED-related technologies from chip to module and circuit fabrication, and nPola, a new LED product based on GaN-substrate technology that achieves more than ten times the output of conventional LEDs. UCD constitutes a high color gamut display which delivers more than 90% NTSC. For more information, please visit www.seoulsemicon.com/en.
LEDVANCE is one of the world‘s leaders in general lighting for lighting professionals as well as end users, offering a broad variety of LED luminaires, advanced LED lamps, intelligent Smart Home & Smart Building solutions as well as traditional light sources.
Emerged from the general lighting business of OSRAM, the company is now owned by Chinese lighting company MLS Co., LTD. With offices in more than 50 countries and business activities in more than 140 countries, LEDVANCE possesses an outstanding global market access built on trusted, long-standing customer relationships and a powerful distribution network. Based on our in-depth understanding of the general lighting market, trending technologies and changing needs, we support the specific and individual demands of both direct and indirect customers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Seoul Semiconductor Co., Ltd.
Tel: +49 89 450 36 90
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IPS acquires Linesight and partners for strategic growth18.10.2021 16:00:00 CEST | Press release
IPS-Integrated Project Services, LLC, headquartered in Blue Bell, Pennsylvania and a subsidiary of Alleghany Capital Corporation, today announced that it has acquired Linesight, a multinational consulting firm headquartered in Dublin, Ireland. IPS is a large EPCMV (Engineering, Procurement, Construction Management and Validation) company with over 1,700 staff across 22 offices worldwide. Linesight is a fast-growing professional consultancy services organization providing project controls to data center providers, life sciences companies, commercial real estate, healthcare, hospitality, retail and residential sectors. Linesight has over 900 staff across 24 offices globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211018005645/en/ The acquisition is being approached as a future integrated partnership where IPS will leverage Linesight’s experience and expertise in particular in the data center sector and Linesight in tur
Attensi og Eggs design vant innovasjonskontrakt med St. Olav. Skal lage neste generasjons trening for helsearbeidere og studenter innen psykisk helse18.10.2021 15:53:00 CEST | Pressemelding
Gode ferdigheter i å «lese», tolke og håndtere ulike møter med personer med psykiske lidelser tar tid å utvikle. For studenter og ansatte i fagfeltet psykisk helse er det utfordrende å få gjennomført tilstrekkelig mengdetrening i tillegg til møter med ekte pasienter. I løpet av de neste 12 månedene vil rundt 20 prosent av befolkningen i Norge ha utviklet en psykisk lidelse (kilde FHI), og riktig vurdering og håndtering er kritisk for en god bedringsprosess. Derfor skal neste generasjons opplæringsløsning nå utvikles, der helsepersonell gjennom bruk av spillelementer og avatarer skal få reell mengdetrening i å observere og videreformidle observasjoner om psykiske utfordringer. Krevende å vurdere riktig Det er et stort antall helsepersonell som er involvert i utredning, diagnostikk og behandling av personer med psykiske lidelser, og det kan være en krevende oppgave. Studenter innenfor helsefag oppgir ofte praksis knyttet til fagområdet psykisk helse som noe de opplever som spesielt kreve
Sumitomo SHI FW (SFW) Add CADMATIC Solutions to Further Support Digitalization, Data-driven Engineering, and Project Management18.10.2021 15:29:00 CEST | Press release
SFW is a provider of power, energy storage and environmental technologies and services for the global energy industry and has now entered into an agreement with CADMATIC Ltd to implement CADMATIC 3D plant design and information management solutions in their engineering projects in Finland, Poland, India, and China. The goal of the investment is to shorten lead times in design, engineering, and construction, improve the quality of design, and harmonize working methods across its international office network and subcontractors. The design and construction of a power plant is an extremely complex process that requires the integration of multiple design, engineering and construction disciplines, and many suppliers. CADMATIC software is an important element to streamline the process from design and engineering to construction and production and seamlessly integrate multiple parties in one project. Technical advantages in 3D Design, work-sharing, information management, and visualization wer
Deel Raises $425M in Series D Funding to Continue Transforming the Future of Work18.10.2021 14:45:00 CEST | Press release
Deel, the remote hiring company shattering job barriers worldwide, announced today that it has raised $425 million in Series D funding, taking the total amount raised by the company to over $630 million. The latest funding round values the company at $5.5 billion. Deel has become the highest valued company in the global hiring, payments, and compliance space with this investment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211018005567/en/ Deel Interface (Graphic: Business Wire) This new funding round was led by US-based Coatue, with partners Rahul Kishore and Lucas Swisher leading the deal. Several new and existing investors also participated in this round, including Altimeter Capital, Andreessen Horowitz, the YC Continuity Fund, Spark Capital, Greenbay Ventures, Neo, and over 40 of the world’s leading operators. Since Deel’s inception in 2019, the team - growing from four to 400 employees - has been on a mission to make
William Shatner Launches Everbridge’s ‘Unlocking Resilience’ Global Leadership Podcast Series, Available Today18.10.2021 14:30:00 CEST | Press release
Everbridge, Inc. (NASDAQ: EVBG) today announced the launch of its podcast Unlocking Resilience™: Global Leadership Seriesfeaturing William Shatner as its inaugural guest. The first-of-its-kind podcast features global influencers, government leaders, C-level executives and top healthcare experts as they discuss the confluence of leadership, technology and resilience at both the personal and organizational level. Topics will include overcoming personal challenges to create a life of resilience; effective strategies for building organizational resilience and business continuity in the face of critical events; and perspectives on the future of work, life and entertainment in a post-pandemic world, among other topics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211018005565/en/ William Shatner Launches Everbridge’s ‘Unlocking Resilience’ Global Leadership Podcast Series, Available Today (Graphic: Business Wire) The Unlocking R
Ferring to Present Award-Winning, Real-World Outcomes Analysis for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection and IBD at ACG 202118.10.2021 14:00:00 CEST | Press release
Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today announced they will present data from two new retrospective analyses as part of American College of Gastroenterology’s Annual Scientific Meeting & Postgraduate Course (ACG 2021). The congress will take place in Las Vegas from October 22 – 27, 2021. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211018005060/en/ Eligibility criteria in CDI clinical trials often are narrowly defined, excluding broader patient populations. The first presentation will explore key health outcomes of RBX2660, an investigational microbiota-based live biotherapeutic for reduction of recurrent C. difficile infection (CDI), among patients in a real-world setting. The second analysis evaluates healthcare resource utilization and medical costs among Medicare patients with CDI with or without inflammatory bowel disease (IBD) as a comorbidity. Notably, one of the presentations has received The
Vertex Announces Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed With VX-880, a Novel Investigational Stem Cell-Derived Therapy for the Treatment of Type 1 Diabetes18.10.2021 13:30:00 CEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive Day 90 data for the first patient from the Phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated pancreatic islet cell replacement therapy for people with type 1 diabetes (T1D). This is the first demonstration of a patient with T1D achieving robust restoration of islet cell function from such a cell therapy. The patient was treated with a single infusion of VX-880 at half the target dose in conjunction with immunosuppressive therapy. The patient achieved successful engraftment and demonstrated rapid and robust improvements in multiple measures, including increases in fasting and stimulated C-peptide, improvements in glycemic control, including HbA1c, and decreases in exogenous insulin requirement. VX-880 was generally well tolerated. “These results from the first patient treated with VX-880 are unprecedented. What makes these results truly remarkable is that they were ac